Skip to main content
Quest Diagnostics

Viral respiratory testing

Determine whether your patient's symptoms are caused by COVID-19, flu, or RSV

Healthcare professionals rely on insights from Quest Diagnostics to make the best choices for their patients. Find molecular respiratory combination testing options, patient care tools, support for your practice, clinical resources, and more. Quest receives respiratory specimens and performs testing nationwide with precision and reliability. Learn more about the test options available to your patients.

COVID-19, flu, and RSV cotests
Important post-PHE testing information

Quest Test Directory

Find all the respiratory testing information you need, including specimen collection and transport requirements, through Quest’s robust Test Directory.

Visit Test Directory

PSC testing availability

SARS-CoV-2 RNA (COVID-19) and Influenza A and B, Qualitative NAAT combination test is available for collection at Quest Patient Service Centers (PSCs) for patients with mild symptoms.
Find a Quest PSC near you
39992-50-50.jpg

Quest tools to enhance care

Quanum® Lab Services Manager

Your practice can rely on the Quanum® Lab Services Manager as a dedicated resource to manage patients, test results, requisitions, and supplies.

Strengthen your practice

MyQuest® portal

Your patients can always access their results directly through their secure MyQuest® account. The online portal is free to set up.

Support your patients

COVID-19 testing statements
  • The Quest Diagnostics molecular test, the other authorized molecular tests (together the “molecular tests”), the COVID/Flu molecular test, the COVID/Flu/RSV test, and the antibody test (together “the tests”) have not been FDA cleared or approved;
  • The tests have been authorized by FDA under an EUA for use by authorized laboratories;
  • The molecular tests have been authorized only for the unsupervised self-collection and maintenance of nasal specimens for the detection of nucleic acid from SARS CoV-2, not for any other viruses or pathogens;
  • The COVID/Flu molecular test and self-collection kit have been authorized only for the unsupervised self-collection and maintenance of nasal specimens for as an aid in detection of nucleic acid from SARS-CoV-2 and influenza A virus and influenza B virus, not for any other viruses or pathogens;
  • The COVID/Flu/RSV test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens;
  • The antibody test has been authorized only for the detection of IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens; and,
  • The tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

Questions?

For more information on our SARS-CoV-2 (COVID-19) testing solutions, or to set up a Quest account, connect with a Quest representative.

Contact us

COVID-19

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.